Community/Retail

As growing levels of antibiotic resistance continues to concern health care professionals, the results of a recent study suggest that giving daily probiotic supplements to children can reduce their likelihood of requiring antibiotics.

Some researchers propose that vasomotor symptoms may signal physiologic processes that might be associated with other related systemic health diagnoses.

Presenters at the International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland identified the current landscape of Hepatitis C, how pharmacists can position themselves to aid in point of care testing, and ways to better educate patients and providers.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Officials with the FDA have approved AstraZeneca’s moxetumomab pasudotox-tdfk (Lumoxiti) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least 2 prior systemic therapies.

A second unexpected impurity was shown in 3 lots of Torrent Pharmaceuticals’ recalled drug products during an ongoing FDA investigation.

The FDA has accepted for review Regeneron Pharmaceuticals’ supplemental Biologics License Application of aflibercept (EYLEA Injection) to treat diabetic retinopathy.

A recent survey evaluated the baseline knowledge of licensed pharmacists with regard to common pet toxins.

A study examined whether silymarin, is an active extract of milk thistle, has a therapeutic effect and can improve hepatic enzyme measures.

Having an emergency plan helps pharmacists, pharmacies, and patients protect themselves and their medications, during a disaster event and in the aftermath.

Azathioprine is known to cause increased photosensitivity to UVA light, but the new findings indicate an association between the drug and the mutational signature found in cases of cutaneous squamous cell carcinoma.

More than half of Americans tested misused their prescription drugs in 2017.

Public action to prevent suicide becomes crucial, as suicide rates rise in almost every state.

Our inability to convince anti-vaccination individuals that immunization is prudent has resulted in increased incidences of some vaccine preventable diseases.

Walgreens announced it will acquire pharmacy patient prescription files and related pharmacy inventory of 185 Fred’s stores located across 10 Southeastern states.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

At the International Pharmaceutical Federation (FIP) World Congress in Glasgow Scotland, speakers reviewed principles of pharmacogenomics and demonstrated useful strategies for utilizing pharmacogenomics in a clinical setting.

GADIS was first launched in December 2011 to connect practicing DI specialists to each other and promote information sharing among pharmacists.

Officials with the FDA have approved Grifols’ new formulation of immune globulin (GamaSTAN) for hepatitis A virus and measles post-exposure prophylaxis.

Officials with the FDA have approved a new dosage strength (16 milligrams/4 milligrams) of buprenorphine and naloxone sublingual film (Cassipa, Teva Pharmaceuticals) for the maintenance treatment of opioid dependence.

Presenters delved into the topic of biological drugs and gene therapy during the recent International Pharmaceutical Federation (FIP) World Congress in Glasgow Scotland.

Two speakers faced off during a session at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow, Scotland, about whether these products have merit.

The role of pharmacists in these causes and natural disasters continues to evolve as organizers and policymakers understand the value that they bring to these events.

Although statins have been linked to benefits among older patients with cardiovascular disease, the results of a recent study indicate that there is insufficient evidence to recommend the drug class’ widespread use in healthy adults over the age of 75.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The FDA has approved riluzole (Tigultik, ITF Pharma) oral suspension for the treatment of amyotrophic lateral sclerosis (ALS).

The American Society of Health-System Pharmacists said it will offer instruction to pharmacists who are practicing or have trained outside the United States.

In this clip, Laura Davis Taylor and Ed King, co-founders of The High Street Collective share their 5 tips to make your pharmacy stand out and keep customers coming back.